RNAssist sponsors the 23rd Genomic Standards Consortium Meeting
We are delighted to announce our sponsorship
vivoPHIX™, genoPHIX™ and virusPHIX™
Choose a category:
We are delighted to attend the 2nd Annual mRNA-Based Therapeutics Summit 24th-26th January 2023 in Berlin. Following the successful development of vaccines against Covid-19, biopharma hopes to deploy mRNA-based therapies to combat many other diseases in oncology, rare disorders, and beyond. The meeting is an ideal opportunity for us to meet colleagues from across the entire mRNA spectrum.
RNAssist technology supports a wide range of life science applications, including tissue fixation and dissociation, single-cell multiomics (scRNA-seq, CITE-seq), and virus inactivation and transport for enhanced diagnostic testing.
Follow us on LinkedIn
© RNAssist | www.RNAssist.com